Eugenio Pacifico
Research Subjects
Eugenio Pacifico has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Antonio De Giuseppe
Istituto Zooprofilattico Sperimentale dell’Umbria e delle Marche “Togo Rosati”, 06126 Perugia, Italy
1 shared publication - Cristina Casciari
National Reference Centre for Infectious Bovine Rhinotracheitis, Istituto Zooprofilattico Sperimentale Umbria-Marche, “Togo Rosati”, 06084 Perugia, Italy
1 shared publication - Elisabetta Manuali
Istituto Zooprofilattico Sperimentale dell’Umbria e delle Marche, Via G. Salvemini 1, 06126 Perugia, Italy
1 shared publication - Francesco Feliziani
National Reference Laboratory for Pestivirus and Asfivirus, Istituto Zooprofilattico Sperimentale dell’Umbria e delle Marche “Togo Rosati”, 06126 Perugia, Italy
1 shared publication - Karol Pawłowski
Warsaw Univ Life Sci SGGW, Fac Vet Med, Dept Physiol Sci, PL-02776 Warsaw, Poland
1 shared publication - Katia Forti
Istituto Zooprofilattico Sperimentale dell’Umbria e delle Marche “Togo Rosati” (IZSUM), Via G. Salvemini 1, 06126 Perugia, Italy
1 shared publication
Latest Publications
- Open Access
- 1 January 2012
- Published by Springer Nature in BMC Veterinary Research
- Vol. 8 (1) , 86
CA 15–3 cell lines and tissue expression in canine mammary cancer and the correlation between serum levels and tumour histological grade
Mammary tumours are the most common malignancy diagnosed in female dogs and a significant cause of mortality and morbidity in this species. Carbohydrate antigen (CA) 15–3 is a mucinous glycoprotein aberrantly over-expressed in human mammary neoplasms and one of the most widely used serum tumour markers in women with breast cancer. The aim of this study was to investigate the antigenic analogies of human and canine CA 15–3 and to assess its expression in canine mammary cancer tissues and cell lines. Immunohistochemical expression of CA 15–3 was evaluated in 7 canine mammary cancer cell lines and 50 malignant mammary tumours. As a positive control, the human breast carcinoma cell line MCF7 and tissue were used. To assess CA 15–3 staining, a semi-quantitative method was applied. To confirm the specificity and cross-reactivity of an anti-human CA 15–3 antibody to canine tissues, an immunoblot analysis was performed. We also investigated serum CA 15–3 activity to establish whether its expression could be assigned to several tumour characteristics to evaluate its potential use as a serum tumour marker in the canine mammary oncology field.
- 1 January 2012
- Published by Springer Nature in BMC Veterinary Research
- Vol. 8 (1) , 86
Open AccessCA 15–3 cell lines and tissue expression in canine mammary cancer and the correlation between serum levels and tumour histological grade
Mammary tumours are the most common malignancy diagnosed in female dogs and a significant cause of mortality and morbidity in this species. Carbohydrate antigen (CA) 15–3 is a mucinous glycoprotein aberrantly over-expressed in human mammary neoplasms and one of the most widely used serum tumour markers in women with breast cancer. The aim of this study was to investigate the antigenic analogies of human and canine CA 15–3 and to assess its expression in canine mammary cancer tissues and cell lines. Immunohistochemical expression of CA 15–3 was evaluated in 7 canine mammary cancer cell lines and 50 malignant mammary tumours. As a positive control, the human breast carcinoma cell line MCF7 and tissue were used. To assess CA 15–3 staining, a semi-quantitative method was applied. To confirm the specificity and cross-reactivity of an anti-human CA 15–3 antibody to canine tissues, an immunoblot analysis was performed. We also investigated serum CA 15–3 activity to establish whether its expression could be assigned to several tumour characteristics to evaluate its potential use as a serum tumour marker in the canine mammary oncology field.